Search

everythinglearnresearchcommunity

for

Search:↓

Extracellular vesicles may effectively treat hair loss with minimal side effects.

Both surgical and non-surgical hair loss treatments lack a standard treatment plan and sufficient patient satisfaction data.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Use minoxidil for hair loss treatment; assess results after 6 months.

A 2-year-old boy grew excessive hair after using minoxidil for hair loss, but it improved when the treatment stopped.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Finasteride helps hair growth but may cause sexual side effects and depression.

Stress worsens hair loss in androgenetic alopecia.

Over half of young people in Saudi Arabia experience early gray hair, linked to factors like smoking, stress, and family history.

Some alternative treatments for hair loss might work, but more research is needed.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Dutasteride is the most effective hair loss treatment after 24 weeks, but finasteride leads to the most hair growth after 48 weeks.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Some treatments for hair loss, like finasteride, biotin, and minoxidil, can be effective, but their success varies by individual case.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Researchers found a genetic link for hereditary hair loss but need more analysis to identify the exact gene.

Genetic factors could lead to personalized treatments for hair loss.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

N-acetyl-cysteine shows promise in treating various diseases and may improve skin and hair conditions, but more research is needed on dosages and long-term effects.

Antigens from skin cells may cause hair loss in perinevoid alopecia.

Minoxidil and finasteride work best for hair loss; more research needed.

Dermatologists recommend oral dutasteride for male hair loss, low-dose oral minoxidil for female hair loss, and a multidisciplinary approach for young patients, with caution during pregnancy.